hitting a plateau on semaglutide 3 Steps to Breaking Weight Loss Ozempic [Complete Guide] Patients Hitting GLP-1 Plateaus? Here's

doi: 10.1172/JCI112855

Glucagon-like peptide-1 (GLP-1) receptor agonists are a family of antihyperglycemic drugs that have demonstrated potent HbA1c reduction, low risk of hypoglycemia, with associated weight reduction, and proven cardiovascular and renal benefits.24 In this review we describe this type of drugs, their cardiovascular and renal benefits, as well as their clinical potential in patients with DKD, especially with the new oral semaglutide formulation, now available on the market

Summary: There is no universal medical requirement to gradually wean off GLP-1 receptor agonists, as they do not typically cause physical dependence or withdrawal symptoms requiring dose tapering

Certain seminal peptides influence sperm motility, adhesion to the oocyte, and polyspermy prevention, suggesting cross-talk between peptide systems in fertility